Market Capitalization of Nath Bio-Genes (NATHBIOGEN)
As of April 30, 2026, Nath Bio-Genes (NATHBIOGEN) market capitalisation is ₹326.87 Cr ($36.32M), with 1.67 Cr shares outstanding at a current price of ₹196.01 on NSE, ranking 2164 out of 5362 companies by market cap in our screener. Nath Bio-Genes operates in the FMCG sector and is classified as a Small Cap stock. For live price, earnings and the complete company profile, see Nath Bio-Genes share price chart.
Market Cap History of Nath Bio-Genes (Last 10 Years)
NATHBIOGEN market capitalisation from year-end NSE closing prices over the last 10 years. Browse NATHBIOGEN quarterly financials for revenue, profit, balance sheet and cash flow data.
End of Year Market Cap History — Nath Bio-Genes
NATHBIOGEN year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Review NATHBIOGEN price earnings ratio to evaluate earnings-based valuation against sector peers.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹326.87 Cr
$36.32M USD
|
₹196.01 | NSE | +26.06% |
| 2025 |
₹259.30 Cr
$28.81M USD
|
₹155.49 | NSE | -17.36% |
| 2024 |
₹313.76 Cr
$34.86M USD
|
₹188.15 | BSE | -9.26% |
| 2023 |
₹345.78 Cr
$38.42M USD
|
₹207.35 | BSE | +28.31% |
| 2022 |
₹269.49 Cr
$29.94M USD
|
₹161.60 | BSE | -39.06% |
| 2021 |
₹442.25 Cr
$49.14M USD
|
₹265.20 | BSE | -3.51% |
| 2020 |
₹458.35 Cr
$50.93M USD
|
₹274.85 | BSE | -20.40% |
| 2019 |
₹575.83 Cr
$63.98M USD
|
₹345.30 | BSE | -16.94% |
| 2018 |
₹693.23 Cr
$77.03M USD
|
₹415.70 | BSE | -10.10% |
| 2017 |
₹771.11 Cr
$85.68M USD
|
₹462.40 | BSE | +212.43% |
| 2016 |
₹246.81 Cr
$27.42M USD
|
₹148.00 | BSE | +89.99% |
| 2015 |
₹129.91 Cr
$14.43M USD
|
₹77.90 | BSE | -38.59% |
| 2014 |
₹211.54 Cr
$23.50M USD
|
₹126.85 | BSE | - |